Viewing Study NCT00868166


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2026-01-20 @ 4:23 PM
Study NCT ID: NCT00868166
Status: COMPLETED
Last Update Posted: 2020-02-25
First Post: 2009-03-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of TRO19622 as add-on Therapy to Riluzole Versus Placebo in Treatment of Patients Suffering From ALS
Sponsor: Hoffmann-La Roche
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-04-30
Start Date Type: ACTUAL
Primary Completion Date: 2011-09-30
Primary Completion Date Type: ACTUAL
Completion Date: 2011-09-30
Completion Date Type: ACTUAL
First Submit Date: 2009-03-23
First Submit QC Date: None
Study First Post Date: 2009-03-24
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2014-11-24
Results First Submit QC Date: None
Results First Post Date: 2019-02-15
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-02-22
Last Update Post Date: 2020-02-25
Last Update Post Date Type: ACTUAL